- Feel Therapeutics unveils the Feel Monitor, a cutting-edge wearable device integrated with AI for mental health monitoring.
- The device employs advanced sensor technology and AI algorithms to provide real-time insights into mood, stress, sleep, and other mental health indicators.
- Feel’s platform enables personalized interventions and support based on digital, behavioral, and physiological data.
- The company’s Emotion AI technology has been recognized with patents and is backed by peer-reviewed research.
- CEO George Eleftheriou emphasizes the potential for personalized mental health care through continuous monitoring and intervention.
Main AI News:
Feel Therapeutics, the forefront Digital Precision Medicine firm focusing on mental and behavioral health, introduces its latest innovation: the Feel Monitor. This state-of-the-art wearable device, integrated with AI technology, establishes a new benchmark in mental health monitoring, meticulously developed in accordance with the FDA’s QMSR standards for medical apparatus.
The prevalence of mental health disorders, notably anxiety and depression, has reached unprecedented levels. Correspondingly, the demand for mental health assistance has soared, underscoring the necessity for objective assessment in a domain traditionally reliant on subjective self-reported surveys.
“Feel Therapeutics is dedicated to engineering technology attuned to individuals’ emotional and mental well-being. Our latest wearable device represents the culmination of advanced sensor technology, coupled with AI, to furnish real-time actionable insights, empowering individuals to access personalized support and attention when it matters most,” emphasized Dr. Haris Tsirmpas, co-founder, and CTO of Feel Therapeutics.
The Feel Monitor distinguishes itself from other wearables through its sophisticated sensor array and advanced AI capabilities. Incorporating five sensors, including continuous Electrodermal Activity and Photoplethysmography sensors, it passively and continuously monitors indicators linked to fluctuations in mood, stress, sleep, psychomotor activity, and other crucial aspects of mental health.
Simultaneously, their advanced emotion and mental health AI platform facilitate tailored, data-driven interventions and assistance to enhance patient outcomes. Harnessing digital, behavioral, and physiological data in the age of multimodal GEN AI, Feel is poised to enable Personal Mental Health LLM models, offering personalized emotional well-being coaching and support in the immediate future.
In a notable departure within the wearable landscape, Feel transcends physical health to concentrate on the next frontier of wearable AI for mental health. Supported by numerous peer-reviewed publications and numerous studies involving thousands of participants, Feel has underscored the efficacy of its platform in identifying digital biomarkers for mental health based on physiological and behavioral data. The company recently secured a second patent from the USPTO for its Emotion AI technology and anticipates several more in therapeutic domains such as Depression, Anxiety, Sleep Disorders, and ADHD.
George Eleftheriou, CEO of Feel Therapeutics, asserts, “Our wearable AI for mental health, leveraging physiological inputs from the new Feel Monitor, represents a genuine differentiator in the marketplace and propels us closer to our objective of revolutionizing the diagnosis, management, and care of mental health. Analogous to our endeavors in other medical spheres like diabetes or heart disease, through continuous and unobtrusive monitoring, we envisage delivering personalized interventions and support for mental health imminently.”
Conclusion:
Feel Therapeutics’ introduction of the Feel Monitor marks a significant advancement in the market for wearable AI devices tailored to mental health monitoring. With its innovative technology and data-driven approach, Feel is poised to meet the growing demand for personalized mental health solutions, potentially reshaping how mental health is diagnosed and managed in the future.
